- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05471310
Videoocular Assessment of Eye Movement Activity in an Ataxia Telangiectasia
July 20, 2022 updated by: Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Eye-tacking Method as a Diagnostic Tool for Assessment of Oculomotor Parameters (Gaze-holding Score, Scan Path, Visually Guided Saccades Etc) in Pediatric Patients With Ataxia Telangiectasia
Ataxia-telangiectasia (A-T) is a multisystem auto-somal recessive disorder linked to the A-T mutated gene (ATM) on chromosome 11q22-23, and characterized by progressive neural degeneration, immunodeficiency, and progressive ocular motor dysfunction.
In previous studies, the quantitative description of the ocular motor deficits from clinical examination was limited to various defects in saccade and gaze control, dysmetric saccades, impairments of smooth pursuit, gaze holding, convergence, vestibular and optokinetic nystagmus slow phases, and cancellation of the vestibulo-ocular reflex.
The aim of our research is to add existing findings with quantitative description of oculomotor patterns in A-T patients using videooculography (VOG).
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
5
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Chéjov, Russian Federation, 142321
- Clinical Rehabilitation Research Center "Russkoe pole"
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 17 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The young citizens of Russia suffered from ataxia telangiectasia.
Description
Inclusion Criteria:
- confirmed diagnosis of ataxia telangiectasia,
- informed consent,
- stay at the Clinical Research Rehabilitation Center "Russkoe Pole" for 14 days.
Exclusion Criteria:
- epilepsy,
- poor visual acuity, inability to percept from a computer monitor,
- inability to hold head and posture satisfactory to perform the tasks,
- difficulty to obtain adequate recordings due to corrective lenses,
- visual field defects.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gaze holding task
Time Frame: baseline, during the intervention-rehabilitation course (once)
|
A fixation task in which the subject will require to look at a target-a green circle (diameter ~1) sequentially presented at eccentric (15 rightward and leftward, 8 upward and downward) positions, each eccentric position being sustained for 20 s.
Gaze-holding score will be assessed for each circle by approximating the gaze position coordinates by the least squares method to obtain the best correspondence using the fit function.
The areas of the obtained ellipses, reflecting the spread of gaze position coordinates, will be determined for each of the four circle positions in each subject.
Areas will be expressed in square visual degrees (sq.
deg.)
|
baseline, during the intervention-rehabilitation course (once)
|
|
Visual search task
Time Frame: baseline, during the intervention-rehabilitation course (once)
|
Ten black circles (diameter ~1) will be presented on the monitor distributed pseudorandomly over the screen.
Subjects will be instructed to count silently the number of points and give a verbal response.
Study parameters: the performance time, the number of fixations, their durations, the total length of the scanning trajectory, and the saccade amplitude.
|
baseline, during the intervention-rehabilitation course (once)
|
|
Visually guided saccade task
Time Frame: baseline, during the intervention-rehabilitation course (once)
|
The subject will be required to follow a target jumping their gaze from one corner of the square to the next as quickly as possible as soon as a circle appeared; saccades will be required in order to do this (An image of a square with side length 10° will be presented on the monitor and a red circle (diameter ~1°) appeared in the corners sequentially in the clockwise direction.)
Study parameters: the total number of saccades completed, the proportions of relatively accurate (A in the range 8.5-11.5°),
hypometric (short, A < 8.5°), and hypermetric (long, A > 11.5°), and corrective saccades (occurring only after dysmetric saccades, 1.5° < A < 5°);
|
baseline, during the intervention-rehabilitation course (once)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Scale for the assessment and rating of ataxia
Time Frame: baseline, during the intervention-rehabilitation course (once)
|
A clinical scale that is based on a semi-quantitative assessment of cerebellar ataxia on an impairment level.
|
baseline, during the intervention-rehabilitation course (once)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Alexander F. Karelin, PhD, Clinical Rehabilitation Research Center "Russkoe pole"
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 15, 2021
Primary Completion (Actual)
March 31, 2022
Study Completion (Actual)
June 30, 2022
Study Registration Dates
First Submitted
April 7, 2022
First Submitted That Met QC Criteria
July 20, 2022
First Posted (Actual)
July 22, 2022
Study Record Updates
Last Update Posted (Actual)
July 22, 2022
Last Update Submitted That Met QC Criteria
July 20, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Metabolic Diseases
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Neurologic Manifestations
- Genetic Diseases, Inborn
- Dyskinesias
- DNA Repair-Deficiency Disorders
- Neurocutaneous Syndromes
- Cerebellar Diseases
- Primary Immunodeficiency Diseases
- Spinocerebellar Ataxias
- Ataxia
- Telangiectasis
- Cerebellar Ataxia
- Ataxia Telangiectasia
Other Study ID Numbers
- LB_03/17/22
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ataxia Telangiectasia
-
Matrix Biomed, Inc.The University of Texas Health Science Center, HoustonNot yet recruitingAtaxia Telangiectasia | Ataxia Telangiectasia Louis-Bar | Ataxia Telangiectasia in ChildrenUnited States
-
IntraBio IncActive, not recruitingAtaxia-Telangiectasia | Ataxia-Telangiectasia (A-T)United States, Spain, Germany, United Kingdom, Switzerland, Slovakia
-
Johns Hopkins UniversityTerminatedAtaxia-Telangiectasia (A-T)United States
-
NHS TaysideUniversity of DundeeCompletedAtaxia-TelangiectasiaUnited Kingdom
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI); Children's Hospital of PhiladelphiaCompletedAtaxia-TelangiectasiaUnited States
-
Institute of Child HealthGreat Ormond Street Hospital for Children NHS Foundation TrustCompletedAtaxia Telangiectasia (AT)United Kingdom
-
IntraBio IncAvailableAtaxia-Telangiectasia (A-T)
-
University of PlymouthRecruitingAtaxia Telangiectasia | Ataxia Telangiectasia in ChildrenUnited Kingdom
-
Acasti Pharma Inc.Active, not recruitingAtaxia TelangiectasiaCanada
-
University Hospital, AkershusOslo University Hospital; University Hospital of North Norway; University of... and other collaboratorsActive, not recruitingAtaxia TelangiectasiaNorway